Showing results (1031-1040 of 1,128) with videos related to

Sort By:
Pageof 113
The Review of Scientific Instruments|July 2, 2010
Diagnostics for first plasma and development plan on KSTARJ H Lee, H K Na, S G Lee, et al.
The Oncologist|September 23, 2017
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER TrialAndrew H Ko, Patrick B Murphy, James D Peyton, et al.
Nature Communications|July 30, 2013
The origin of antiferroelectricity in PbZrO₃A K Tagantsev, K Vaideeswaran, S B Vakhrushev, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 21, 2010
Comparison of the efficacy and safety of tramadol/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathyS-H Ko, H-S Kwon, J-M Yu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2016
A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomasS J Kim, D-Y Shin, J S Kim, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 24, 2014
Risk factors for cytomegalovirus gastrointestinal diseases in adult patients with cancerJ-H Ko, K R Peck, W J Lee, et al.
Leukemia|February 13, 2013
Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotypeS-Y Tan, S-S Chuang, T Tang, et al.
Plos One|December 1, 2023
A medium-chain fatty acid analogue prevents hepatosteatosis and decreases inflammatory lipid metabolites in a murine model of parenteral nutrition-induced hepatosteatosisBennet S Cho, Scott C Fligor, Gillian L Fell, et al.
Neuro-Oncology|March 23, 2026
Recent progress and future directions to advance glioblastoma research: A consensus perspective from the 2024 Christopher Davidson ForumGavin P Dunn, Kenny K H Yu, Max O Krucoff, et al.
Pancreas|March 19, 2004
Expression of the intermediate filament vimentin in proliferating duct cells as a marker of pancreatic precursor cellsS H Ko, S H Suh, B J Kim, et al.
Pageof 113